Literature DB >> 12360411

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families.

Sophie Gad1, Virginie Caux-Moncoutier, Sabine Pagès-Berhouet, Marion Gauthier-Villars, Isabelle Coupier, Pascal Pujol, Marc Frénay, Brigitte Gilbert, Christine Maugard, Yves-Jean Bignon, Annie Chevrier, Annick Rossi, Jean-Pierre Fricker, Tan Dat Nguyen, Liliane Demange, Alain Aurias, Aaron Bensimon, Dominique Stoppa-Lyonnet.   

Abstract

Genetic linkage data have shown that alterations of the BRCA1 gene are responsible for the majority of hereditary breast-ovarian cancers. However, BRCA1 germline mutations are found much less frequently than expected, especially as standard PCR-based mutation detection approaches focus on point and small gene alterations. In order to estimate the contribution of large gene rearrangements to the BRCA1 mutation spectrum, we have extensively analysed a series of 120 French breast-ovarian cancer cases. Thirty-eight were previously found carrier of a BRCA1 point mutation, 14 of a BRCA2 point mutation and one case has previously been reported as carrier of a large BRCA1 deletion. The remaining 67 cases were studied using the BRCA1 bar code approach on combed DNA which allows a panoramic view of the BRCA1 region. Three additional rearrangements were detected: a recurrent 23.8 kb deletion of exons 8-13, a 17.2 kb duplication of exons 3-8 and a 8.6 kb duplication of exons 18-20. Thus, in our series, BRCA1 large rearrangements accounted for 3.3% (4/120) of breast-ovarian cancer cases and 9.5% (4/42) of the BRCA1 gene mutation spectrum, suggesting that their screening is an important step that should be now systematically included in genetic testing surveys.

Entities:  

Mesh:

Year:  2002        PMID: 12360411     DOI: 10.1038/sj.onc.1205685

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

2.  Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene.

Authors:  C Dehainault; A Laugé; V Caux-Moncoutier; S Pagès-Berhouet; F Doz; L Desjardins; J Couturier; M Gauthier-Villars; D Stoppa-Lyonnet; C Houdayer
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

3.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients.

Authors:  David Ellis; Yogen Patel; Shu C Yau; Shirley V Hodgson; Stephen J Abbs
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

5.  BAP1 and breast cancer risk.

Authors:  Isabelle Coupier; Pierre-Yves Cousin; David Hughes; Patricia Legoix-Né; Alexandra Trehin; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification.

Authors:  Vahid R Yassaee; Babak Emamalizadeh; Mir Davood Omrani
Journal:  J Genet       Date:  2013-04       Impact factor: 1.166

7.  BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.

Authors:  Ana Peixoto; Natália Salgueiro; Catarina Santos; Graça Varzim; Patrícia Rocha; Maria José Soares; Deolinda Pereira; Helena Rodrigues; Maria José Bento; António Fráguas; Graça Moura; Fernando Regateiro; Sérgio Castedo; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

8.  Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.

Authors:  Abhijit Chakraborty; Ashis Mukhopadhyay; Deboshree Bhattacharyya; Chinmoy Kr Bose; Keya Choudhuri; Soma Mukhopadhyay; Jayasri Basak
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

9.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701

10.  Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Authors:  Tal Distelman-Menachem; Tal Shapira; Yael Laitman; Bella Kaufman; Frida Barak; Sean Tavtigian; Eitan Friedman
Journal:  Fam Cancer       Date:  2008-09-17       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.